シャルコー・マリー・トゥース病の世界市場レポート 2025年

シャルコー・マリー・トゥース病市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR20.6％で28億米ドルに成長します。予測期間の成長は、遺伝性疾患の早期スクリーニングプログラムの実施、神経・筋専門クリニックの拡大、希少疾患治療に対する償還施策の改善、遺伝子検査に対する保険適用範囲の拡大、ヘルスケア支出の増加に起因しています。この期間に予想される主要動向としては、疾患修飾療法の臨床検査の進行、有望な新薬候補の強力なパイプライン、希少疾患治療に対する製薬会社の投資の拡大、研究開発インセンティブを高める希少疾病用医薬品の指定、遺伝子治療や遺伝子編集技術の進歩などが挙げられます。

ヘルスケア支出の増加は、今後数年間のシャルコー・マリー・トゥース（CMT）病市場の成長を牽引すると予想されます。ヘルスケア支出とは、医療サービス、消耗品、健康の維持・改善に焦点を当てた活動に対する支出総額を指します。この支出は、最先端の医療技術の進歩や導入により増加しており、研究、機器、専門的なトレーニングへの多額の投資が必要となるため、医療費全体の増加につながっています。ヘルスケア支出の増加は、専門的治療、診断ツール、支援ケアサービスへのアクセスを向上させ、疾病管理の改善につながることで、CMT治療への投資を促進します。例えば、2025年4月、英国の政府機関Office for National Statisticsは、2023～2024年にかけてのヘルスケア支出が6.5%増加すると報告しました。このように、ヘルスケア支出の継続的な急増は、シャルコー・マリー・トゥース病市場の拡大を後押しするものと考えられます。

シャルコー・マリー・トゥース（CMT）病市場の主要企業は、間葉系幹細胞治療のような、様々な組織ソースからの単離・拡大が容易な先進治療の開発に注力しています。間葉系幹細胞治療は、多様な健康状態において治癒を促進し炎症を抑えるために、複数の組織型に分化できる万能細胞を利用します。例えば、2025年3月、韓国のENCell Co.Ltd.は、米国食品医薬品局（FDA）より、CMT治療用の間葉系幹細胞治療EN001が希少疾病用医薬品（オーファンドラッグ）に指定されたと発表しました。EN001は、細胞の生存率を高め、治療用分子の放出を促進することを目的としています。投与により、神経修復を対象とし、治癒因子の放出を刺激し、神経の再髄鞘化をサポートします。1a型CMT患者を対象とした第1相非盲検用量漸増臨床検査（NCT05333406）が実施され、3+3検査デザインに従い、16週間にわたって安全性、忍容性、至適投与量が評価されました。低用量群の参加者は初日に静脈内投与を受けた。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のシャルコー・マリー・トゥース病：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のシャルコー・マリー・トゥース病市場：成長率分析
• 世界のシャルコー・マリー・トゥース病市場の実績：規模と成長、2019～2024年
• 世界のシャルコー・マリー・トゥース病市場の予測：規模と成長、2024～2029年、2034年
• 世界のシャルコー・マリー・トゥース病：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のシャルコー・マリー・トゥース病市場：疾患タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• CMT1
• CMT2
• CMT3
• その他の疾患タイプ
• 世界のシャルコー・マリー・トゥース病市場：薬剤タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 非ステロイド性抗炎症薬
• シクロオキシゲナーゼ-2阻害剤
• 三環系抗うつ薬
• 抗けいれん薬
• 鎮痛剤
• パイプライン医薬品
• 世界のシャルコー・マリー・トゥース病市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域別・国別分析

• 世界のシャルコー・マリー・トゥース病市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のシャルコー・マリー・トゥース病市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• シャルコー・マリー・トゥース病市場：競合情勢
• シャルコー・マリー・トゥース病市場：企業プロファイル
  • F-Hoffmann-La-Roche-Ltd
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Biogen Inc.

第31章 その他の大手企業と革新的企業

• Sarepta Therapeutics Inc.
• Chong Kun Dang Pharmaceutical Corp.
• Ionis Pharmaceuticals Inc.
• Ultragenyx Pharmaceutical Inc.
• Acceleron Pharma
• Affectis Pharmaceuticals AG
• NMD Pharma
• Pharnext SA
• MedDay Pharmaceuticals
• Inflectis BioScience
• Helixmith Co. Ltd.
• Addex Therapeutics
• Augustine Therapeutics
• DTx Pharma Inc.
• ENCell Co.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• シャルコー・マリー・トゥース病市場、2029年：新たな機会を提供する国
• シャルコー・マリー・トゥース病市場、2029年：新たな機会を提供するセグメント
• シャルコー・マリー・トゥース病市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Charcot-marie-tooth (CMT) disease refers to a group of inherited neurological disorders that impact the peripheral nerves, which are responsible for muscle control and transmitting sensory information from the limbs to the brain. It is marked by progressive muscle weakness and atrophy, particularly in the feet, lower legs, hands, and forearms, often accompanied by sensory loss, foot deformities (such as high arches or hammertoes), and difficulty with walking. CMT is caused by genetic mutations that disrupt the structure or function of peripheral nerves. The condition usually begins during adolescence or early adulthood, though the age of onset and severity may differ among individuals.

The primary types of charcot-marie-tooth disease include CMT 1, CMT 2, CMT 3, and others. Type 1 CMT (CMT 1) is a hereditary neuropathy resulting from abnormalities in the myelin sheath that insulates peripheral nerves. Treatment involves various drug types, including nonsteroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase-2 inhibitors, tricyclic antidepressants, anticonvulsants, analgesics, and drugs currently in the pipeline. These medications are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The charcot-marie-tooth disease market research report is one of a series of new reports from The Business Research Company that provides charcot-marie-tooth disease market statistics, including charcot-marie-tooth disease industry global market size, regional shares, competitors with a charcot-marie-tooth disease market share, detailed charcot-marie-tooth disease market segments, market trends and opportunities, and any further data you may need to thrive in the charcot-marie-tooth disease industry. This charcot-marie-tooth disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The charcot-marie-tooth disease market size has grown exponentially in recent years. It will grow from $1.09 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 20.9%. Growth during the historic period can be attributed to rising public awareness of genetic neuropathies, increased utilization of genetic counseling services, greater physician education on rare diseases, strengthened patient advocacy initiatives, and broader access to neurophysiological testing.

The charcot-marie-tooth disease market size is expected to see exponential growth in the next few years. It will grow to $2.80 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. Growth in the forecast period can be attributed to the implementation of early screening programs for inherited disorders, the expansion of neurology and neuromuscular specialty clinics, improved reimbursement policies for rare disease treatments, broader insurance coverage for genetic testing, and increased healthcare spending. Key trends expected during this period include ongoing clinical trials for disease-modifying therapies, a strong pipeline of promising drug candidates, growing investment by pharmaceutical companies in rare disease treatments, orphan drug designations that enhance research and development incentives, and advancements in gene therapy and gene editing technologies.

The rise in healthcare expenditure is expected to drive the growth of the Charcot-Marie-Tooth (CMT) disease market in the coming years. Healthcare expenditure refers to the total spending on medical services, supplies, and activities focused on maintaining or improving health. This expenditure is increasing due to the advancement and adoption of cutting-edge medical technologies, which require significant investment in research, equipment, and specialized training-contributing to higher overall healthcare costs. The growth in healthcare spending facilitates greater investment in CMT treatment by enhancing access to specialized therapies, diagnostic tools, and supportive care services, leading to improved disease management. For example, in April 2025, the Office for National Statistics, a UK-based government agency, reported a 6.5% increase in healthcare spending from 2023 to 2024, slightly higher than the 6.3% rise recorded in 2023. Thus, the continued surge in healthcare expenditure is set to support the expansion of the Charcot-Marie-Tooth disease market.

Leading companies in the Charcot-Marie-Tooth (CMT) disease market are concentrating on developing advanced therapies, such as mesenchymal stem cell treatments, which offer ease of isolation and expansion from various tissue sources. Mesenchymal stem cell therapies utilize versatile cells capable of differentiating into multiple tissue types to promote healing and reduce inflammation in diverse health conditions. For example, in March 2025, ENCell Co. Ltd., a South Korea-based biopharmaceutical firm, announced that the U.S. Food and Drug Administration granted orphan drug designation to EN001, a mesenchymal stem cell therapy designed to treat CMT disease. EN001 aims to enhance cell survival and boost the release of therapeutic molecules. Upon administration, the therapy targets nerve repair, stimulates the release of healing factors, and supports nerve remyelination. A phase 1 open-label, dose-escalation clinical trial (NCT05333406) was conducted involving patients with type 1a CMT to evaluate safety, tolerability, and optimal dosing over 16 weeks, following a 3+3 trial design. Participants in the low-dose group received an intravenous dose on the first day.

In November 2024, the Charcot-Marie-Tooth Association (CMTA), a U.S.-based non-profit organization, partnered with the Inherited Neuropathy Consortium (INC) to advance comprehensive research across all variants of Charcot-Marie-Tooth disease. This collaboration aims to accelerate the translation of research into clinical applications, pushing treatments forward and offering hope to individuals affected by Charcot-Marie-Tooth. The Inherited Neuropathy Consortium (INC) is a U.S.-based clinical research consortium focused on rare diseases.

Major players in the charcot-marie-tooth disease market are F-Hoffmann-La-Roche-Ltd, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, Biogen Inc., Sarepta Therapeutics Inc., Chong Kun Dang Pharmaceutical Corp., Ionis Pharmaceuticals Inc., Ultragenyx Pharmaceutical Inc., Acceleron Pharma, Affectis Pharmaceuticals AG, NMD Pharma, Pharnext SA, MedDay Pharmaceuticals, Inflectis BioScience, Helixmith Co. Ltd., Addex Therapeutics, Augustine Therapeutics, DTx Pharma Inc., ENCell Co.

North America was the largest region in the charcot-marie-tooth disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in charcot-marie-tooth disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the charcot-marie-tooth disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The charcot-marie-tooth disease market consists of revenues earned by entities by providing services such as genetic testing services, physical therapy services, occupational therapy services, and orthotic fitting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The charcot-marie-tooth disease market also includes sales of custom insoles, mobility aids, electrostimulation devices, and compression garments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Charcot-Marie-Tooth Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on charcot-marie-tooth disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for charcot-marie-tooth disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The charcot-marie-tooth disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: CMT 1; CMT 2; CMT 3; Other Disease Types
• 2) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs; Cyclooxygenase-2 Inhibitors; Tricyclic Antidepressants; Anticonvulsants; Analgesics; Pipeline Drug
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Companies Mentioned: F-Hoffmann-La-Roche-Ltd; Sanofi SA; Bristol-Myers Squibb Company; Novartis AG; Biogen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Charcot-Marie-Tooth Disease Market Characteristics

3. Charcot-Marie-Tooth Disease Market Trends And Strategies

4. Charcot-Marie-Tooth Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Charcot-Marie-Tooth Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Charcot-Marie-Tooth Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Charcot-Marie-Tooth Disease Market Growth Rate Analysis
• 5.4. Global Charcot-Marie-Tooth Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Charcot-Marie-Tooth Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Charcot-Marie-Tooth Disease Total Addressable Market (TAM)

6. Charcot-Marie-Tooth Disease Market Segmentation

• 6.1. Global Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CMT 1
• CMT 2
• CMT 3
• Other Disease Types
• 6.2. Global Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs
• Cyclooxygenase-2 Inhibitors
• Tricyclic Antidepressants
• Anticonvulsants
• Analgesics
• Pipeline Drug
• 6.3. Global Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Charcot-Marie-Tooth Disease Market Regional And Country Analysis

• 7.1. Global Charcot-Marie-Tooth Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Charcot-Marie-Tooth Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Charcot-Marie-Tooth Disease Market

• 8.1. Asia-Pacific Charcot-Marie-Tooth Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Charcot-Marie-Tooth Disease Market

• 9.1. China Charcot-Marie-Tooth Disease Market Overview
• 9.2. China Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Charcot-Marie-Tooth Disease Market

• 10.1. India Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Charcot-Marie-Tooth Disease Market

• 11.1. Japan Charcot-Marie-Tooth Disease Market Overview
• 11.2. Japan Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Charcot-Marie-Tooth Disease Market

• 12.1. Australia Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Charcot-Marie-Tooth Disease Market

• 13.1. Indonesia Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Charcot-Marie-Tooth Disease Market

• 14.1. South Korea Charcot-Marie-Tooth Disease Market Overview
• 14.2. South Korea Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Charcot-Marie-Tooth Disease Market

• 15.1. Western Europe Charcot-Marie-Tooth Disease Market Overview
• 15.2. Western Europe Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Charcot-Marie-Tooth Disease Market

• 16.1. UK Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Charcot-Marie-Tooth Disease Market

• 17.1. Germany Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Charcot-Marie-Tooth Disease Market

• 18.1. France Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Charcot-Marie-Tooth Disease Market

• 19.1. Italy Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Charcot-Marie-Tooth Disease Market

• 20.1. Spain Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Charcot-Marie-Tooth Disease Market

• 21.1. Eastern Europe Charcot-Marie-Tooth Disease Market Overview
• 21.2. Eastern Europe Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Charcot-Marie-Tooth Disease Market

• 22.1. Russia Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Charcot-Marie-Tooth Disease Market

• 23.1. North America Charcot-Marie-Tooth Disease Market Overview
• 23.2. North America Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Charcot-Marie-Tooth Disease Market

• 24.1. USA Charcot-Marie-Tooth Disease Market Overview
• 24.2. USA Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Charcot-Marie-Tooth Disease Market

• 25.1. Canada Charcot-Marie-Tooth Disease Market Overview
• 25.2. Canada Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Charcot-Marie-Tooth Disease Market

• 26.1. South America Charcot-Marie-Tooth Disease Market Overview
• 26.2. South America Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Charcot-Marie-Tooth Disease Market

• 27.1. Brazil Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Charcot-Marie-Tooth Disease Market

• 28.1. Middle East Charcot-Marie-Tooth Disease Market Overview
• 28.2. Middle East Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Charcot-Marie-Tooth Disease Market

• 29.1. Africa Charcot-Marie-Tooth Disease Market Overview
• 29.2. Africa Charcot-Marie-Tooth Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Charcot-Marie-Tooth Disease Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Charcot-Marie-Tooth Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Charcot-Marie-Tooth Disease Market Competitive Landscape And Company Profiles

• 30.1. Charcot-Marie-Tooth Disease Market Competitive Landscape
• 30.2. Charcot-Marie-Tooth Disease Market Company Profiles
  • 30.2.1. F-Hoffmann-La-Roche-Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Charcot-Marie-Tooth Disease Market Other Major And Innovative Companies

• 31.1. Sarepta Therapeutics Inc.
• 31.2. Chong Kun Dang Pharmaceutical Corp.
• 31.3. Ionis Pharmaceuticals Inc.
• 31.4. Ultragenyx Pharmaceutical Inc.
• 31.5. Acceleron Pharma
• 31.6. Affectis Pharmaceuticals AG
• 31.7. NMD Pharma
• 31.8. Pharnext SA
• 31.9. MedDay Pharmaceuticals
• 31.10. Inflectis BioScience
• 31.11. Helixmith Co. Ltd.
• 31.12. Addex Therapeutics
• 31.13. Augustine Therapeutics
• 31.14. DTx Pharma Inc.
• 31.15. ENCell Co.

32. Global Charcot-Marie-Tooth Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Charcot-Marie-Tooth Disease Market

34. Recent Developments In The Charcot-Marie-Tooth Disease Market

35. Charcot-Marie-Tooth Disease Market High Potential Countries, Segments and Strategies

• 35.1 Charcot-Marie-Tooth Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Charcot-Marie-Tooth Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Charcot-Marie-Tooth Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer